Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:40:26 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Q:STIM - NEURONETICS INC - http://www.Stimsonite.Com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
STIM - Q0.12.47·15.002.03.49-0.03-0.944.61294303.52  3.55  3.3455.0699  1.0316:00:05Apr 2315 min RT 2¢

Recent Trades - Last 10 of 430
Time ETExPriceChangeVolume
16:00:05Q3.49-0.03417
16:00:02Q3.49-0.0350
16:00:01Q3.49-0.03500
16:00:01Q3.49-0.032
16:00:01Q3.49-0.034
16:00:01Q3.49-0.038
16:00:01Q3.49-0.0363
16:00:01Q3.49-0.03377
16:00:01Q3.49-0.0350
15:59:57Q3.48-0.04100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-23 16:30U:STIMNews ReleaseNeuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
2024-04-10 08:31U:STIMNews ReleaseNew Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
2024-03-27 16:30U:STIMNews ReleaseNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2024-03-25 08:30U:STIMNews ReleaseNeuroStar(TM) Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
2024-03-07 08:22U:STIMNews ReleaseNeuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
2024-03-05 07:30U:STIMNews ReleaseNeuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
2024-02-20 08:30U:STIMNews ReleaseNeuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call
2024-02-12 08:32U:STIMNews ReleaseNeuronetics Launches Latest Evolution in its TrakStar ‚ ® Patient Data Management System
2024-02-06 08:28U:STIMNews ReleaseNeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
2024-01-08 08:30U:STIMNews ReleaseNeuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
2023-12-18 08:49U:STIMNews ReleaseNeuronetics Receives 510(k) Clearance for NeuroSite ¢ „ ¢ ‚  Coil Placement Accessory
2023-12-04 08:56U:STIMNews ReleaseNeuroStar TMS Receives Expanded Regulatory Approval in Japan
2023-11-15 16:15U:STIMNews ReleaseNeuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference
2023-11-13 08:57U:STIMNews ReleaseNeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
2023-11-09 08:32U:STIMNews ReleaseNeuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
2023-11-07 07:30U:STIMNews ReleaseNeuronetics Reports Third Quarter 2023 Financial and Operating Results
2023-11-06 16:30U:STIMNews ReleaseNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2023-10-24 08:30U:STIMNews ReleaseNeuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call
2023-10-16 08:56U:STIMNews ReleaseBrain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
2023-10-03 09:21U:STIMNews ReleaseNeuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility